Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population

Am J Hum Biol. 2012 Jul-Aug;24(4):454-9. doi: 10.1002/ajhb.22245. Epub 2012 Mar 12.

Abstract

Objectives: The worldwide increasing prevalence of obesity is considered as a major health problem. Peroxisome proliferator-activated receptor gamma (PPAR-γ) controls adipocyte differentiation and regulates a number of genes associated with energy homeostasis. In this study, we investigated the association of PPAR-γ gene Pro12Ala (rs1801282) and C1431T (rs3856806) polymorphisms with morbid obesity and related phenotypes, in north Indian population.

Methods: A total of 6,42 subjects, 309, obese and 333 nonobese individuals were included in this case-control study. Insulin, adiponectin, glucose, and lipid levels were estimated using standard protocols. All subjects were genotyped by PCR restriction fragment length polymorphism (PCR-RFLP) method.

Results: The ProAla+AlaAla genotypes of PPAR-γ Pro12Ala were significantly associated with higher risk of obesity while C1431T polymorphism did not show any significant association. None of the haplotypes showed association with morbid obesity. However, a strong association of variant genotypes was observed with higher levels of insulin, HOMA-IR, and lower serum adiponectin concentrations.

Conclusion: PPAR-γ gene polymorphisms influence obesity and obesity phenotype in a complex manner, probably involving insulin resistance in north Indian population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adipose Tissue / physiology
  • Adult
  • Blood Glucose / analysis
  • Blood Pressure
  • Female
  • Gene Frequency*
  • Haplotypes*
  • Humans
  • Indien
  • Insulin / blood
  • Insulin Resistance
  • Lipids / blood
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / genetics*
  • Obesity / physiopathology
  • PPAR gamma / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Risk Factors
  • Young Adult

Substances

  • Adiponectin
  • Blood Glucose
  • Insulin
  • Lipids
  • PPAR gamma